Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7511905 | 0.84 | FFAR3 (0.33) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL28612384 | 0.82 | TSHR (0.50) | TSHRALDH1A1HPGDATMCES2 | |
| SCHEMBL3731627 | 0.78 | FFAR3 (0.34) | TSHRALDH1A1FFAR3HDAC3HDAC1 | |
| SCHEMBL29206154 | 0.78 | TSHR (0.38) | TSHR | |
| SCHEMBL3477377 | 0.76 | TSHR (0.55) | TSHRALDH1A1HPGDATMDGKA | |
| SCHEMBL4931188 | 0.74 | FFAR3 (0.31) | ALDH1A1FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL11696010 | 0.74 | ALDH1A1 (0.52) | TSHRALDH1A1HPGDATMDGKA | |
| SCHEMBL3804221 | 0.71 | LMNA (0.36) | TSHRALDH1A1CA1CES2CES1 | |
| SCHEMBL3194379 | 0.71 | CA1 (0.34) | TSHRALDH1A1HPGDCA1CES2 | |
| SCHEMBL3478058 | 0.71 | TSHR (0.63) | TSHRALDH1A1HPGDATMDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112533910-B | Monoethylenically unsaturated monomers and their use | 博斯蒂克股份公司 | 2024-05-10 | — | — | CN | claimed |
| US-20080114125-A1 | Methods for Producing Crosslinkable Oligomers | NUPLEX RESINS B.V. (NL) | 2008-05-15 | — | — | US | claimed |
| CN-112533910-B | Monoethylenically unsaturated monomers and their use | 博斯蒂克股份公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-113825776-B | Polymers having an upper critical dissolution temperature in aqueous solution | 波音公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116211887-A | Composition for treating acid-base imbalance | 特里赛达公司 | 2023-06-06 | — | — | CN | disclosed |
| EP-3789413-B1 | STATISTICAL COPOLYMER LATEX AND USE THEREOF, AND PRODUCTION METHOD FOR STATISTICAL COPOLYMER LATEX | DENKA COMPANY LTD (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3789413-A1 | STATISTICAL COPOLYMER LATEX AND USE THEREOF, AND PRODUCTION METHOD FOR STATISTICAL COPOLYMER LATEX | Denka Company Limited (JP) | 2021-03-10 | — | — | EP | disclosed |
| US-20200275650-A1 | NOVEL POLYMER COATED CHLOROTHALONIL PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2020-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200275650-A1 | NOVEL POLYMER COATED CHLOROTHALONIL PARTICLES | PGLS, CLTA, PICALM | TSHR 4815/4885ALDH1A1 4196/4885HPGD 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.